newsfilter
← Latest News
ACCESS Newswire·

Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study

WHO Technical Advisory Group recommends mRNA-1469 for inclusion in efficacy study following encouraging Phase 1 clinical results CAMBRIDGE, MA / ACCESS Newswire / November 4, 2026 / Moderna, Inc.